Nadav Eshkol

Development Manager
Pluristem Therapeutics

Nadav Eshkol is the Development Manager at Pluristem Therapeutics, a clinical-stage biotherapy company using placental cells to develop cell therapies for several indications such as inflammation, ischemia, muscle injuries, hematological disorders and exposure to radiation. Holding a Bachelor’s degree in Biotechnology from the Technion – Israel Institute of Technology. Nadav has been working in Pluristem in various process engineering, process development and project management roles for 8 years. Expertise in cells manufacturing processes, innovative technology development, projects and teams management and technology transfer to production. Previous to Pluristem, Nadav has worked for 5 years in the semiconductors industry, as a process engineer in Tower-Jazz Semiconductors.

Check out the incredible speaker line-up to see who will be joining Nadav.

Download The Latest Agenda

Day 2 - System Management

Wednesday, February 19th, 2020

11:00 AM INTERACTIVE DISCUSSION GROUPS

During this part of the summit, delegates will be sorted into groups of 10-12 to take part in interactive discussions around the topics below. Delegates will get the opportunity to select and pre-register for the topics. Discussion groups are kept small to ensure all delegates get the opportunity to ask their most pressing questions, ensuring a perfectly tailored experience.

•The Shelf Life of Expensive Articles

Philipp Wolf, Expert Biopharmaceutical Single Use Equipment, Boehringer Ingelheim

•Supplier Material Qualification of Disposables – Standardization & Challenges

Laura O’Connell, Manufacturing Process Specialist, Janssen

•Lessons Learnt Working with Different DSP Single Use Systems

James Pullen, Director of Downstream Processing, Fujifilm Diosynth Biotech

•The Challenges and Opportunities of Using Disposables in Cell Therapy Manufacturing

Nadav Eshkol, Development Manager, Pluristem Therapeutics

•Using New Technology to Industrialise SU Solutions

Amir Goudarzi, Head of Process Engineering, UCB

•Next-Generation Sampling and Process Monitoring

Marc-Antoine Kaag, Global Product Manager Sampling, Merck

Day 3 - Future Technology

Thursday, February 20th, 2020

12:10 PM Keeping Up with the Future Demand for ATMPs: The Challenges and Opportunities of Using Disposables in Cell Therapy Manufacturing

· Discuss the uniqueness of cell therapy and the challenges in using full disposable process

· Understand the preparations for manufacturing up scaling and readiness for marketing demands

· What is the best point to move to full SU manufacturing process?